Luca Healthcare Partners with Cambridge Cognition to Launch Cognitive Tools in China
China-based digital health solutions provider Luca Healthcare has announced a strategic partnership and license agreement...
Luye Pharma’s Biosimilar to Amgen’s Xgeva Launched in China
China-based Luye Pharma Group (HKG: 2186) has announced the first prescription of its biosimilar version...
Assure Tech Wins Japanese PDMA Approval for Pen-Type COVID-19 Antigen Test
China-based Assure Tech (Hangzhou) Co., Ltd (SHA: 688075) has announced receiving marketing approval from Japan’s...
Double-Crane Pharma Gains NMPA Approval for COVID-19 Drug CX2101A Clinical Trials
China Resources Double-Crane Pharmaceutical Co., Ltd (SHA: 600062) has announced receiving clinical trial approval from...
Lepu Medical Wins NMPA Approval for Disposable Pressure Microcatheter
China-based cardiovascular disease solutions provider Lepu Medical Technology (Beijing) Co., Ltd (SHE: 300003) has announced...
China’s NMPA Shifts to Electronic Drug Filings from January 2023
China’s National Medical Products Administration (NMPA) has released a notification indicating the initiation of electronic...
Hainan Hospital Launches IBI’s Smartbone ORTHO for Bone Repair
The clinical application of Smartbone ORTHO, a polyester collagen bone repair material introduced by Hainan...
CSL Vifor and Fresenius Kabi Win China Approval for Ferinject
Swiss firm CSL Vifor and Germany’s Fresenius Kabi have announced the first regulatory approval in...
China’s Pharma Firms Collaborate on Generic Version of Sun Pharma’s Carbamazepine
Several China-based pharmaceutical companies, including Shanghai Zhongxi Sunve Pharmaceutical Co. Ltd, Shanghai Anbison Lab Co.,...
Youcare’s YKYYO17 Aerosol Inhalation Agent Approved for COVID-19 Clinical Study
China-based Youcare Pharmaceutical Group’s YKYYO17 aerosol inhalation agent, a broad-spectrum coronavirus membrane fusion inhibitor polypeptide...
Henan Celnovte Biotechnology Raises RMB 100M in New Financing Round
China-based Henan Celnovte Biotechnology Co., Ltd, a tumor in vitro diagnostic reagents (IVDs) and instruments...
Clover Biopharmaceuticals’ SCB-2019 Vaccine Reduces Household Transmission of COVID-19
China-based vaccine specialist Clover Biopharmaceuticals, Ltd (HKG: 2197) announced that Clinical Infectious Diseases has published...
Ascletis Pharma Completes Enrollment for ASC40 Phase II Acne Study
China-based Ascletis Pharma Inc. (HKG: 1672) announced the completion of enrollment of 180 patients in...
Ascletis Pharma’s COVID-19 Drug Candidate ASC11 Accepted for Review by NMPA
China-based Ascletis Pharma Inc. (HKG: 1672) has announced that its Investigational New Drug (IND) filing...
Hangzhou Polymed Biopharmaceuticals Raises Funds for Clinical Pipeline
China-based Hangzhou Polymed Biopharmaceuticals has reportedly completed a Pre-Series A+ financing round, raising an undisclosed...
Fosun Pharma Weighs Sale of India’s Gland Pharma Amid Market Interest
Shanghai Fosun Pharmaceutical Group Co. (HKG: 2196, SHA: 600196) is reportedly considering the sale of...
Fosun Pharma’s Gland Pharma to Acquire French CDMO Cenexi for EUR 120 Million
Shanghai Fosun Pharmaceutical Group Co (SHA: 600196) announced that its India-based subsidiary, Gland Pharma Ltd...
Luye Pharma Initiates Phase II Study for LY 03014 in China
China-based Luye Pharma Group (HKG: 2186) has announced the first patient dosing in a Phase...
China’s Drug-Eluting Stent Procurement Results Announced
The national high-value medical consumables alliance procurement office has released the results of the successive...
Zhejiang Jiuzhou Pharma to Raise RMB 2.5 Billion via Private Placement
China-based Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA: 603456) has received approval from the China Securities...